October 10, 2018
[vc_row][vc_column][vc_column_text] The Drug Development IPO market enjoyed a strong third quarter, with over $3.18B raised by 26 companies across the globe, bringing the year-to-date total up […]
- Filter by
- Categories
- Tags
- Authors
- Show all
- All
- Briefing
- Company News
- Evolution Executive News
- Evolution Infographics
- Insights
- News & Analysis
- News & Analysis
- The Future of BioManufacturing
- Uncategorized
- All
- #biologics #API #Biopharma #hiringtrends #predictivetalentdynamics #CDMO #contractmanufacturing
- 23andMe
- 3M
- 4D Molecular Technologies
- A.I.
- A1M Pharma
- Abcam
- AbClon
- ABL Bio
- ABL Inc
- Ablynx
- Abzena
- Accenture
- ACD Bio
- Actelion
- AdaptImmune
- Adial Pharmaceuticals
- Advanced Scientifics
- Advicenne
- Aenova
- Aesica
- Affymetrix
- Agilent Technologies
- Agricultural Technology
- AGTC
- Akcea Therapeutics
- Akron Biotech
- Alcami
- Alfa Aesar
- Alkahest
- Allakos
- Allergan
- Alligator Bioscience
- Allogene Therapeutics
- Almac
- Alnylam Pharmaceuticals
- Ambrosia
- Amgen
- AMRI
- Annexin Pharmaceuticals
- Applied Genetic Technologies
- Applikon
- Aptinyx
- Aquestive Therapeutics
- Arcturus Therapeutics
- argenx
- Aridis Pharmaceutical
- Arrowhead Pharmaceuticals
- Arvinas
- Arysta LifeScience
- Asarina Pharma
- Ascletis Pharma
- Aslan Pharmaceuticals
- AstraZeneca
- Asymptote
- Athenex
- Atomwise
- Autolus Therapeutics
- Autostem Consortium
- Avacta
- Avalanche Biotechnologies
- Avenue Therapeutics
- AveXis
- Avitide
- Avrobio
- AzurRx
- Batavia Biosciences
- Baxalta
- Bayer
- Bayer CropScience
- BD Biosciences
- Beckman Coulter
- Beigene
- Benevolent AI
- Benitec Biopharma
- Berg Health
- BerGenBio
- Bio-Rad
- Bio-Techne
- Bioarctic B
- Biocon
- Biogen
- BioHaven Pharma
- Bioinformatics
- Biomanufacturing
- Biomarin
- BioOutsource
- Biopharma
- Bioproduction
- BioReliance
- Biosolution
- Biotech
- Blockchain
- bluebird bio
- Boehringer Ingelheim
- Bonesupport
- Brammer Bio
- Bristol-Myers Squibb
- C3i
- Calliditas Therapeutics
- Cambrex
- Cancer Immunotherapy
- Capsugel
- CAR-T
- CardioCell
- Catalent
- Celgene
- Cell Line Engineering
- Cell Therapy
- Cellectis
- Cellivery Therapeutics
- Celsis International
- Celyad
- Cepheid
- Charles River Laboratories
- ChemChina
- Chemicals
- Clementia Pharmaceuticals
- Clinical Diagnostics
- Clinical Trials
- CMC Biologics
- Cobra Biologics
- Codexis
- Cognizant Technology Solutions
- Conference
- Consort Medical
- Constellation Pharmaceuticals
- Corning
- Covance
- CR Pharma
- Creative BioLabs
- Crinetics Pharmaceuticals
- Crispr Therapeutics
- CRO/CMO
- Daiichi Sankyo
- Danaher
- Dante Labs
- Deciphera Pharmaceuticals
- DeCODE Genetics
- Deep Learning
- Deloitte
- Denali Therapeutics
- Dendreon
- Dermapharm
- Diagnostics
- Dicerna Pharmaceuticals
- Downstream Processing
- Drug Development
- Drug Discovery
- eGenesis
- Eidos Therapeutics
- Eli Lilly
- Elsevier
- EMD Millipore
- Entasis Therapeutics
- Entegris
- Entera Bio
- Eris Lifesciences
- Erytech Pharma
- Ethereum
- Eurogentec
- Eutilex
- Evelo Biosciences
- Evidera
- Evolution Global Press Releases
- Evolution Infographics
- Evotec
- Exscientia
- FEI Company
- FiberCell Systems
- FinVector
- FIT Biotech
- Flash Therapeutics
- Flow Cytometry
- Forty Seven
- Fosun Pharma
- Fujifilm Diosynth
- G-CON Manufacturing
- G1 Therapeutics
- GE Healthcare
- Gene Therapy
- Genentech
- Genethon
- Genomics & Proteomics
- Genos
- GenSight Biologics
- Genzyme
- Gilead
- GlaxoSmithKline
- Glycotope
- Google Life Sciences
- Gore
- GoSilico
- Gritstone Oncology
- GSK
- Haemonetics
- Hana Pharma
- Healthcare Analytics
- Helix Illumina
- Hua Medicine
- Hyphens Pharma
- IBM
- ICON plc
- iCure Pharm
- Idorsia
- Illumina
- Immunocore
- Immuron
- In Silico Modelling
- INC Research
- InDex Pharma
- Inflarx
- Informatics & Analytics
- Infosys
- Innovent Biologics
- InSilico Medicine
- InSphero
- Intelligen
- inVentiv Health
- Invesco
- IP Group
- Isofol Medical
- Iterum Therapeutics
- Janssen
- JHL Biotech
- JM Separations
- Johnson & Johnson
- Juno Therapeutics
- Juno Therapeutics Therapeutics
- Junshi Biosciences
- Juvenescence AI
- Kala Pharmaceuticals
- Kantar Health
- Kerry Group
- Kezar Life Sciences
- Kiniksa Pharmaceuticals
- KITE Pharma
- KIYATEC
- Krystal Biotech
- KuBio
- Kyowa Hakko Kirin
- Leica Biosystems
- Life Sciences
- Lion Biotechnologies
- Liquidia Technologies
- Living Cell Technologies
- Lonza
- m&a
- Machine Learning
- Magenta Therapeutics
- MassBiologics
- McKinsey
- Medical Devices
- Medimmune
- Medivation
- MeiraGTx
- Meissner
- Merck
- Merck & Co.
- Mergers Partnerships & Acquisitions
- Mersana Therapeutics
- Mesoblast
- Metagenomics
- MilliporeSigma
- Miltenyi Biotec
- Moderna Therapeutics
- Modular Factories
- Molecular Pathology
- MolMed
- Monsanto
- Morphosys
- Motif Bio
- MultiVir
- Mustang Bio
- Myovant Sciences
- Myriad Genetics
- N4 Pharma
- NantKwest
- Natrix Separations
- Navigo Proteins
- Nebula Genomics
- Neon Therapeutics
- NeuroScientific Biopharmaceuticals
- news
- Next Generation Sequencing
- Nightstar Therapeutics
- Ningbo Menovo
- Northwest Biotherapeutics
- Nortis
- Novartis
- Novasep
- Novo Nordisk
- NuCana
- Octane Biotech
- Octapharma
- OliX Pharmaceuticals
- OncoArendi Therapeutics
- Opko
- Organovo
- Orphazyme
- Ovid Therapeutics
- Oxford Biomedica
- Oxford Genetics
- Oxford Nanopore
- Oxford University
- Pacific Biosciences
- Pall
- Parexel
- Patheon
- PerkinElmer
- Pfizer
- PharmAbcine
- Pharmaron
- Plant Impact
- Polyphor
- PPD
- Precision Medicine
- Press Ganey
- Principia Biopharma
- Promega
- Prometic Bioseparations
- Promore Pharma
- Provention Bio
- Puridify
- Q-Gen Cell Therapeutics
- Qiagen
- QuantiHealth
- Quark Pharmaceuticals
- Quintiles IMS
- RA Pharmaceuticals
- Regenerative Medicine
- Regeneron
- REGENXBIO
- Repligen
- Replimune Group
- Roche
- RTI Health Solutions
- Rubius Therapeutics
- RXi Pharmaceuticals
- Samsung BioLogics
- Sangamo Therapeutics
- Saniona
- Sanofi
- Sartorius Stedim
- Scandinavian Chemotech
- Scarab Genomics
- Scholar Rock
- Seragon
- Shire
- Siegfried
- Sienna Biopharmaceuticals
- Sigma-Aldrich
- Silenseed
- Singulex
- siRNA Therapeutics
- SkinBioTherapeutics
- Spark Therapeutics
- Spinout
- Stem Cells
- StemoniX
- Stempeutics
- Sudhin Biopharma
- Sunovion Pharma
- Surface Oncology
- Sutro Biopharma
- Sylentis
- Symphony Health Solutions
- Syngenta
- Synthon
- SynVivo
- Takara
- Takeda
- Tanvex BioPharma
- TARA
- Tekmira Pharmaceuticals
- Telix Pharma
- Terumo
- Terumo BCT
- Teva Pharmaceuticals
- Texcell
- The Future of BioManufacturing
- The Medicines Company
- Theranexus
- Thermo Fisher Scientific
- Thomson Reuters
- TiGenix
- Tocagen
- Tokyo Electron Limited
- TOSOH Bioscience
- Touchstone Innovations
- Toxicology
- Translate Bio
- Tricida
- Truven
- UCB Pharma
- UniQure
- Unity Biotechnology
- Upstream Processing
- Urogen Pharma
- Urovant Sciences
- Vaccinex
- Valbiotis
- Valeant Pharmaceuticals
- Venture Capital Investment
- Vericel
- Veritas Genetics
- Verona Pharma
- Verrica Pharmaceuticals
- Vetter
- Virology
- ViroMed
- Vivo Science
- Wacker
- Waters
- Woodford Fund
- Wuxi Apptec
- WuXi NextCODE
- WuXi PharmaTech
- Xbrane Biopharma
- Xenotransplantation
- Xeris Pharmaceuticals
- Xspray Pharma
- Y-mAbs Therapeutics
- Zai Lab
- Zealand Pharma
- ZellWerk
- Zymeworks
February 20, 2018
Categories
[vc_row][vc_column][vc_column_text] The Drug Development IPO market enjoyed a strong year in 2018, with over $10.24B raised by 95 companies across 15 global exchanges. When compared to […]
Do you like it?